Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking  adolescent rats. Focus on calcitonin gene-related peptide's brain levels. 2023

Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
Pharmacology Section, Department of Health Care Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Rome, Italy.

Alcohol binge drinking is common among adolescents and may challenge the signalling systems that process affective stimuli, including calcitonin gene-related peptide (CGRP) signalling. Here, we employed a rat model of adolescent binge drinking to evaluate reward-, social- and aversion-related behaviour, glucocorticoid output and CGRP levels in affect-related brain regions. As a potential rescue, the effect of the phytocannabinoid cannabidiol was explored. Adolescent male rats underwent the intermittent 20% alcohol two-bottle choice paradigm; at the binge day (BD) and the 24 h withdrawal day (WD), we assessed CGRP expression in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), amygdala, hypothalamus and brainstem; in addition, we evaluated sucrose preference, social motivation and drive, nociceptive response, and serum corticosterone levels. Cannabidiol (40 mg/kg, i.p.) was administered before each drinking session, and its effect was measured on the above-mentioned readouts. At BD and WD, rats displayed decreased CGRP expression in mPFC, NAc and amygdala; increased CGRP levels in the brainstem; increased response to rewarding- and nociceptive stimuli and decreased social drive; reduced serum corticosterone levels. Cannabidiol reduced alcohol consumption and preference; normalised the abnormal corticolimbic CGRP expression, and the reward and aversion-related hyper-responsivity, as well as glucocorticoid levels in alcohol binge-like drinking rats. Overall, CGRP can represent both a mediator and a target of alcohol binge-like drinking and provides a further piece in the intricate puzzle of alcohol-induced behavioural and neuroendocrine sequelae. CBD shows promising effects in limiting adolescent alcohol binge drinking and rebalancing the bio-behavioural abnormalities.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D008297 Male Males
D002185 Cannabidiol Compound isolated from Cannabis sativa extract. 1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-,Epidiolex
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015740 Calcitonin Gene-Related Peptide A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Calcitonin Gene-Related Peptide I,Calcitonin Gene-Related Peptide II,alpha-CGRP,alpha-Calcitonin Gene-Related Peptide,beta-CGRP,beta-Calcitonin Gene-Related Peptide,Calcitonin Gene Related Peptide,Calcitonin Gene Related Peptide I,Calcitonin Gene Related Peptide II,Gene-Related Peptide, Calcitonin,alpha Calcitonin Gene Related Peptide,beta Calcitonin Gene Related Peptide
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
May 2024, Psychopharmacology,
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
August 2022, Metabolic brain disease,
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
January 2017, Frontiers in psychology,
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
March 2016, Addiction biology,
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
May 2014, Alcohol (Fayetteville, N.Y.),
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
September 1999, The international journal of neuropsychopharmacology,
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
February 2014, Pharmacology, biochemistry, and behavior,
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
March 2015, Alcohol and alcoholism (Oxford, Oxfordshire),
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
April 2023, Progress in neuro-psychopharmacology & biological psychiatry,
Giuseppe Tringali, and Gianluca Lavanco, and Valentina Castelli, and Giuseppe Pizzolanti, and Martin Kuchar, and Diego Currò, and Carla Cannizzaro, and Anna Brancato
June 2015, Adicciones,
Copied contents to your clipboard!